Find a Specialist by Postal Code | Page 11 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Rodrigo Calado, MD, PhD Hospital das Clínicas de Ribeirão Preto Ribeirão Preto São Paulo Brazil
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mark Litzow, MD Mayo Clinic - Rochester Rochester Minnesota United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Mrinal Patniak, MD, MBBS Mayo Clinic Minnesota Rochester Minnesota United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jane Liesveld, MD Strong Memorial Hospital Rochester New York United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Sharon Savage, MD National Cancer Institute – Shady Grove Rockville Maryland United States
  • Aplastic Anemia
  • Pediatric
Srinivas Tantravahi, MBBS, MRCP Huntsman Cancer Hospital Salt Lake City Utah United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Charles J. Parker, MD University of Utah School of Medicine Salt Lake City Utah United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Catherine J. Lee, MD Huntsman Cancer Center, University of Utah Salt Lake City Utah United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Ruben Mesa, MD, FACP Mays Cancer Center at UT Health San Antonio MD Anderson San Antonio Texas United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Tiffany Tanaka, MD UC San Diego Health San Diego California United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Phil Scheinberg, MD Hospital Sao Jose, Beneficencia Portuguesa de Sao Paolo Sao Paulo Brazil
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Katherine Tarlock, MD Seattle Children's Hospital Seattle Washington United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric
H. Joachim Deeg, MD University of Washington and Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Bart Scott, MD Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jun Ho Jang, MD, PhD Samsung Medical Center Seoul South Korea
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Matthew Walter, MD Washington University - Barnes Jewish Hospital St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Stephen Oh, MD Siteman Cancer Center St. Louis Missouri United States
  • Myeloproliferative Neoplasms (MPN)
Geoffrey Uy, MD Siteman Cancer Center St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Peter Westervelt, MD, PhD Siteman Cancer Center St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Tian Yi Zhang, MD, PhD Stanford University School of Medicine Stanford California United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)